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BACKGROUND: Cervical cancer risk is associated with low education even in an unscreened population, but it is not clear whether
human papillomavirus (HPV) infection follows the same pattern.
METHODS: Two large multicentric studies (case–control studies of cervical cancer and HPV prevalence survey) including nearly 20000
women. GP5þ/GP6þ PCR was used to detect HPV.
RESULTS: Education level was consistently associated with cervical cancer risk (odds ratio (OR) for 0 and 45 years vs 1–5
years¼1.50, 95% confidence interval (CI): 1.25–1.80 and 0.69, 95% CI: 0.57–0.82, respectively, P for trend o0.0001). In contrast,
no association emerged between education level and HPV infection in either of the two IARC studies. A majority of the women
studied had never had a Pap smear. The association between low education level and cervical cancer was most strongly attenuated
by adjustment for age at first sexual intercourse and first pregnancy. Parity and screening history (but not lifetime number of sexual
partners, husband’s extramarital sexual relationships, and smoking) also seemed to be important confounding factors.
CONCLUSION: The excess of cervical cancer found in women with a low socio-economic status seems, therefore, not to be explained
by a concomitant excess of HPV prevalence, but rather by early events in a woman’s sexually active life that may modify the cancer-
causing potential of HPV infection.
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Cervical cancer risk is associated with a low socio-economic status
(SES), as defined by education or income levels (Parikh et al,
2003). The reasons for the association are not fully understood but
are thought to include a higher prevalence of cervical cancer risk
factors, such as inadequate cervical cancer screening (Khan et al,
2005), high parity (International Collaboration of Epidemiological
Studies of Cervical Cancer, 2006), and possibly high-risk sexual
behaviour (International Collaboration of Epidemiological Studies
of Cervical Cancer, 2009; Louie et al, 2009) among women with a
low SES (de Sanjose et al, 1997).
It is now believed that the majority of cervical cancer is preceded
by a long-term infection with high-risk types of the human
papillomavirus (HPV), a sexually transmitted infection (Schiffman
et al, 2007). High prevalence of HPV in women with a low SES has
been shown in a few studies (Hildesheim et al, 1993; Lazcano-
Ponce et al, 2001), but has not been confirmed in others (Deacon
et al, 2000; Shapiro et al, 2003; Khan et al, 2005; Banura et al, 2008;
Hibbitts et al, 2008).
We took advantage of two large series of studies coordinated by
the International Agency for Research on Cancer (IARC), that is,
the IARC Multicentric Case–Control Study (Munoz et al, 2002)
and the IARC HPV Prevalence Surveys (Franceschi et al, 2006), to
evaluate the relationship between education level and risk of
cervical cancer and HPV infection.
MATERIALS AND METHODS
The IARC multicentric case–control study
Methods have been described earlier for the 11 individual studies
carried out between 1985 and 1999 that have been included in this
paper (Munoz et al, 1992; Eluf-Neto et al, 1994; Chaouki et al,
1998; Chichareon et al, 1998; Ngelangel et al, 1998; Rolon et al,
2000; Santos et al, 2001; Bayo et al, 2002; Franceschi et al, 2003;
Hammouda et al, 2005). Briefly, eligible cases were residents in
predefined study areas, or women attending reference hospitals
with incident, histologically confirmed invasive cervical cancer.
A total of 2446 cases were identified, including 140 adeno- or
adenosquamous invasive cervical carcinomas from six study areas
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y(Eluf-Neto et al, 1994; Chaouki et al, 1998; Chichareon et al, 1998;
Ngelangel et al, 1998; Rolon et al, 2000; Santos et al, 2001). Control
women were population based in the Spanish and Colombian
studies (Munoz et al, 1992) and hospital or clinic based in other
study areas. They were frequency matched by 5-year age group and
did not include women admitted to hospital for cancers of the
anogenital tract, breast and colon, smoking-related diseases
(Munoz et al, 1992), or sexually transmitted infections (Hammouda
et al, 2005). A total of 2390 control women were included between
1985 and 1999 (Figure 1).
The IARC HPV prevalence surveys
Sampling methods of participating women have already been
described for the 16 individual studies carried out between 1993
and 2006 that are included in this paper (Molano et al, 2002;
Anh et al, 2003; de Sanjose et al, 2003; Matos et al, 2003; Shin
et al, 2003; Sukvirach et al, 2003; Ferreccio et al, 2004; Thomas
et al, 2004; Dai et al, 2006; Li et al, 2006; Wu et al, 2007; Bardin
et al, 2008; Dondog et al, 2008; Keita et al, 2009). Briefly, in each
area attempts were made to obtain a population-based sample that
included at least 100 women in each 5-year age group between 15
or 18 years, and 55 years or older. Participation ranged from 48%
to over 90% and, overall, 15051 women were included. On account
of the need to undergo a gynaecological examination, prevalence
surveys were mainly restricted to women who reported to have had
sexual intercourse and, in some areas, to married women. Few
single women (6% of all study women) and only 90 virgin women
were, therefore, included.
The questionnaires used in both case–control studies and
prevalence surveys included a question with regard to the years of
full-time education and information on lifetime number of sexual
partners, age at first sexual intercourse, husband’s extramarital
sexual relationships, use of oral contraceptives and condom,
parity, age at first pregnancy, smoking, and history of Pap smear.
Among cases, any Pap smear taken less that 1 year before cancer
diagnosis was excluded as they were considered ‘diagnostic
smears’.
All women in both studies signed informed consent forms
according to the recommendations of the IARC and local ethical
review committees, which approved the studies.
HPV detection
HPV testing was performed in the Department of Pathology at the
Vrije University Medical Center, Amsterdam, the Netherlands, as
described in individual study publications. The overall presence of
HPV DNA was determined by performing a general primer GP5þ/
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Figure 1 Distribution of women with and without cervical cancer in the International Agency for Research on Cancer case–control studies and human
papillomavirus prevalence surveys, according to education level, Pap smear history*, and study area. *In case–control studies, Pap smears taken 12 months
before enrolment are excluded.
wStudy areas in Vietnam.
zStudy areas in Thailand.
yStudy areas in China.
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y6þ-mediated PCR (Jacobs et al, 2000). HPV positivity was
assessed by hybridisation of PCR products in an enzyme
immunoassay using two HPV oligoprobe cocktails that, together,
detect the following HPV types: HPV6, 11, 16, 18, 26, 31, 33, 34, 35,
39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 55, 56, 57, 58, 59, 61, 66, 68, 70,
72, 73, 82 (IS39 and MM4 subtypes), 83 (equivalent to MM7), 84
(equivalent to MM8), and CP6108. Subsequent HPV typing was
performed by reverse-line blot hybridisation of PCR products, as
described earlier (Jacobs et al, 1995; van den Brule et al, 2002).
Statistical analysis
Education level was classified into four groups (0, 1–5, 6–10; 410
years). Owing to small numbers, the last two groups were merged in
the case–control studies. Regularised logistic regression
(Gelman et al, 2008) was used to calculate odds ratios (ORs) and
95% confidence intervals (CIs) by education level for cervical cancer
in the case–control studies and for HPV infection among control
women only in case–control studies and among the general female
population in prevalence surveys. The reference category for
education was set to the most common category (i.e., 1–5 years in
case–control studies and 6–10 years in prevalence surveys).
Tests for trend were computed using three or four categories of
education level as continuous variables. All analyses were adjusted
for age (in 5-year groups) and study area. Adjustment was also
made for lifetime number of sexual partners (0–1, 2, X3), age at
first sexual intercourse (o17, 17–20, X21 years), husband’s
extramarital sexual relationships (no, yes, or uncertain), number of
full-term pregnancies (0, 1–2, 3–4, 5–6, X7), age at first
pregnancy (o18, 18–20, X21 years), use of hormonal contra-
ceptives and condom (never, ever), smoking (never, former, ever),
and history of Pap smear (never, ever), as reported.
Heterogeneity of ORs between study areas was tested by fitting
separate models to each area and then comparing the observed
with the expected dispersion of estimates around the pooled mean
using a w
2 statistic. For purposes of assessing heterogeneity, study
areas with five or fewer individuals in a given category of
education were not considered, as they could not provide OR
estimates. All statistical tests were two-sided.
Results in the text are presented as ORs with conventional CIs.
Where results are presented in the form of plots, floating absolute
risks (Plummer, 2004) were used to represent the dose–response
relationship in a way independent of the choice of reference
category. ORs are represented by squares and their corresponding
floating CIs by horizontal lines. The position of the square
indicates the point estimate of the OR, and the area of the square is
inversely proportional to the square of the floating standard error
on the log scale, thus providing an indication of the amount of
statistical information available.
RESULTS
Figure 1 shows the number of women included in each study and
the broad variations in education level across study areas. Among
cervical cancer cases, 82% (range: 53–100%) reported 5 years of
education or less. The percentage of women who reported 5 years
of education or less was 66% (range 29–93%) among control
women in the IARC Multicentric Case–Control Study and 34%
(range: 2–71%) among the general female population in the IARC
HPV Prevalence Surveys (Figure 1). Large variations were also
found in the proportion of women who reported to have had a Pap
smear, averaging 23% (range: 0–64%) and 37% (range: 0–78%)
among cervical cancer cases and control women, respectively, in
case–control studies, and 42% (range: 0–93%) among women in
prevalence surveys (Figure 1).
Education level was associated with cervical cancer risk (OR for
0 and 45 years vs 1–5 years¼1.50, 95% CI: 1.25–1.80; and 0.69,
95% CI: 0.57–0.82, respectively, P for trend o0.0001) in case–
control studies (Figure 2A). The association was similar in all
study areas and no statistically significant heterogeneity emerged.
When the association between education level and risk of adeno-
or adenosquamous carcinoma was evaluated separately, findings
were similar to those for all cervical cancers (OR for 0 and 45
years vs 1–5 years¼1.80, 95% CI: 1.11–2.91; and 0.76, 95% CI:
0.47–1.24, respectively, data not shown). In contrast, education
level was not associated with HPV positivity among control women
(OR for 0 and 45 years vs 1–5 years¼1.04, 95% CI: 0.63–1.40;
and 0.94, 95% CI: 0.63–1.40) (Figure 2B).
In agreement with the findings among control women in the
case–control studies, no association between education level and
HPV positivity was found among the larger number of women
included in the prevalence surveys (OR for 410, 1–5, and 0 years
vs 6–10 years¼1.03, 95% CI: 0.90–1.18; 0.88, 95% CI: 0.76–1.02;
and 1.06, 95% CI: 0.87–1.28, respectively, P for trend¼0.67)
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Figure 2 Odds ratios (OR)
w and corresponding 95% confidence
intervals (CI) for (A) cervical cancer risk and (B) human papillomavirus
(HPV) positivity among control women only. The International Agency for
Research on Cancer Multicentric Case–Control Study. FSE¼floating
standard error, HPV¼human papillomavirus.
wAdjusted for age, study area,
lifetime number of sexual partners, age at first sexual intercourse, husbands’
extramarital sexual relationships, parity, age at first pregnancy, oral
contraceptive use, and history of Pap smear.
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Figure 3 Odds ratios (OR)
w and corresponding 95% confidence
intervals (CI) for human papillomavirus (HPV) positivity by education level.
The International Agency for Research on Cancer HPV Prevalence Surveys.
FSE¼floating standard error.
wAdjusted for age, study area, lifetime number
of sexual partners, age at first sexual intercourse, husbands’ extramarital
sexual relationships and history of Pap smear.
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with some non-statistically significant associations in either
direction, no significant heterogeneity was found between study
areas with respect to HPV infection and education level.
The influence of adjusting for different confounding variables
on the association between cervical cancer risk and education
(dichotomised as p5 and 45 years) in the case–control studies is
shown in Table 1. The age- and study area-adjusted OR (2.64, 95%
CI: 2.27–3.06) was most strongly attenuated by adjustment for age
at first sexual intercourse (OR¼2.03, 95% CI: 1.73–2.37) and age
at first pregnancy (OR¼2.13, 95% CI: 1.80–2.52). Adjustment for
parity, use of oral contraceptives, and history of Pap smear also
somewhat diminished the OR by education level, whereas
adjustment for lifetime number of sexual partners, husband’s
extramarital sexual relationships, condom use, and tobacco
smoking did not. The fully adjusted OR for p5 vs 45 years of
education was 1.41 (95% CI: 1.11–1.79), that is, 47% lower than the
OR adjusted for age and study area only.
DISCUSSION
Education level was inversely and consistently associated with
cervical cancer risk, but not with HPV prevalence, in a broad range
of world populations included in the IARC studies. The lack of
excess of HPV positivity in low-education women was consistently
found among control women in case–control studies (i.e., in the
same population in which the association between low-education
level and cervical excess risk emerged), as well as in the larger
number of women included in the HPV prevalence surveys that
were carried out in part in different countries than the case–
control studies.
Obviously, education level cannot be considered as a well-
defined exposure, but as a marker for a combination of
characteristics that predominate among women with a low SES.
The aim of our study was not, therefore, to rule out bias and
confounding, but rather to evaluate the principal risk factors
responsible for any socio-economic gradient.
In screened populations, education level is most likely to be a
surrogate of inadequate screening (Khan et al, 2005), but a socio-
economic gradient in cervical cancer risk was reported long before
screening programmes were introduced (Jones et al, 1958) and is
still seen in countries where little screening activity exists
(Franceschi et al, 2003; Parikh et al, 2003). Such was the case in
our combined analysis; although in some study areas, a large
fraction of women who reported to have had at least one Pap
smear taken in their lifetime and screening history did have an
influence on the association with education level, nowhere did
broad-coverage and high-quality screening programmes exist at
the time our studies took place (Konno et al, 2008; Murillo et al,
2008).
A substantial fraction of the influence of socio-economic
gradient on cervical cancer risk in our study was explained by
the early age of first sexual intercourse and first pregnancy (Louie
et al, 2009), as well as by high parity, whereas lifetime number of
sexual partners and husband’s extramarital sexual relationships
did not seem to be important confounding factors. Similarly,
adjustment for the presence of HPV infection among cervical
cancer cases and controls or restriction to HPV-positive women, as
carried out in some earlier reports from the IARC case–control
study (Munoz et al, 2002), left the association with low education
level unchanged (data not shown).
The weaknesses of this study include the limitation in the
completeness and quality of information available on SES, which
led us to use education level only as a proxy of SES, and on
possible confounding factors, notably sexual behaviour and
screening history. Residual confounding, therefore, probably still
inflates the association between cervical cancer risk and education
in our report. This problem does not eclipse, however, the clear
difference we found between cervical cancer and HPV positivity
with respect to SES. Additional information on SES (e.g., income,
ownership of the house, and number of appliances and facilities at
home) and husband’s sexual behaviour (e.g., sexual intercourses
with prostitutes) (de Sanjose et al, 1997) was included in some
studies that are a part of this report. These variables, however,
were missing for a substantial proportion of women and, in the
case of SES indicators, were highly correlated with education level.
The strengths of this study are the large number of women
included, the performance of high-quality HPV testing, and the
relatively modest impact of cervical cancer screening in the
majority of populations in which IARC studies have been
performed that allowed other correlates of low education level
other than screening to emerge more clearly.
Our findings imply that higher HPV prevalence and lifetime
number of sexual partners do not explain the excess of cervical
cancer in women with low SES. Conversely, early events that can
modify the carcinogenic potential of HPV infection, such as early
age of first intercourse (a possible proxy of longer duration of
uncleared HPV infection (International Collaboration of Epide-
miological Studies of Cervical Cancer, 2009)) and early and
multiple pregnancies (International Collaboration of Epidemiolo-
gical Studies of Cervical Cancer, 2006) account for a large part of
the SES gradient of cervical cancer, at least in inadequately
screened populations.
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